Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator

Journal of Physiology

Volumn 587, Issue 12, 2009, Pages 2875-2886

  Aleksandrov, Andrei A ^a,b,c   Cui, Liying ^b   Riordan, John R ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; NUCLEOSIDE TRIPHOSPHATE; TRANSMEMBRANE CONDUCTANCE REGULATOR; AMINO ACID; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ION CHANNEL;

AMINO ACID SUBSTITUTION; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; ATP HYDROLYSIS; CHANNEL GATING; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; HUMAN; HUMAN CELL; HYDROLYSIS KINETICS; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE BINDING SITE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RATE EQUILIBRIUM FREE ENERGY RELATIONSHIP; ALLOSTERISM; BINDING SITE; CROSS LINKING; CYTOPLASM; HYDROLYSIS; NUCLEOTIDE BINDING; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOPLASM; ENERGY TRANSFER; HUMANS; ION CHANNEL GATING; KINETICS; LIGANDS; MUTATION; NUCLEOTIDES;

EID: 67649659825     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.170258     Document Type: Article

References (49)

1. Aleksandrov AA & Riordan JR (1998). Regulation of CFTR ion channel gating by MgATP. FEBS Lett 431, 97-101.
2. Aleksandrov AA, Chang X-B, Aleksandrov L & Riordan JR (2000). The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating. J Physiol 528, 259-265.
3. Aleksandrov AA, Aleksandrov L & Riordan JR (2002). Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis. FEBS Lett 518, 183-188.
4. Aleksandrov AA, Aleksandrov LA & Riordan JR (2007). CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. Pflugers Arch 453, 693-702.
5. Astumian RD (1997). Thermodynamics and kinetics of a Brownian motor. Science 276, 917-922.
6. Auerbach A (2003). Life at the top: The transition state of AChR gating. Sci STKE 188. re11.
7. Auerbach A (2007). How to turn the reaction coordinate into time. J Gen Physiol 130, 543-546.
8. Baker JMR, Hudson RP, Kanelis V, Choy WY, Thibodeau PH, Thomas PJ & Forman-Kay JD (2007). CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struc Mol Biol 14, 738-745.
9. Beck EJ, Yang Y, Yaemsiri S & Raghuram V (2008). Conformational changes in a pore-lining helix coupled to cystic fibrosis transmembrane conductance regulator channel gating. J Biol Chem 283, 4957-4966.
10. Carson MR, Travis SM, Winter MC, Sheppard DN & Welsh MJ (1994). Phosphate stimulates CFTR Cl -channels. Biophys J 67, 1867-1875.
11. Chang X-B, Tabcharani JA, Hou Y-X, Jensen TJ, Kartner N, Alon N, Hanrahan JW & Riordan JR (1993). Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem 268, 11304-11311.
12. Cheung M & Akabas MH (1996). Identification of cystic fibrosis transmembrane conductance regulator channel-lining residues in and flanking the M6 membrane-spanning segment. Biophys J 70, 2688-2695.
13. Colquhoun D (1998). Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125, 923-948.
14. Colquhoun D (2005). From shut to open: What can we learn from linear free energy relationships. Biophy J 89, 3673-3675.
15. Colquhoun D (2006). Agonist-activated ion channels. Br J Pharmacol 147, S17-S26.
16. Cotten JF, Ostedgaard LS, Carson MR & Welsh MJ (1996). Effect of cystic fibrosys-associated mutations in the fourth intracellular loop of cystic fibrosys transmembrane conductance regulator. J Biol Chem 271, 21279-21284.
17. Csanady L, Nairn AC & Gadsby DN (2006). Thermodynamics of CFTR channel gating: A spreading conformational change initiates an irreversible gating cycle. J Gen Physiol 128, 523-533.
18. Cui L, Aleksandrov L, Chang X-B, Hou Y-X, He L, Hegedus T, Gentzsch M, Aleksandrov A, Balch WE & Riordan JR (2007). Domain interdependence in the biosynthetic assembly of CFTR. J Mol Biol 365, 981-994.
19. Cui L, Aleksandrov L, Hou Y-X, Gentzsch M, Chen J-H, Riordan JR & Aleksandrov AA (2006). The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating. J Physiol 572, 347-358.
20. Dawson RJP & Locher KP (2006). Structure of a bacterial multidrug ABC transporter. Nature 443, 180-185.
21. Del Castillo J & Katz B (1957). Interaction at end-plate receptors between different choline derivatives. Proc Roy Soc Lond B Biol Sci 146, 369-381.
22. Du R, Pande VS, Grosberg AY, Tanaka T & Shakhnovich ES (1998). On the transition coordinate for protein folding. J Chem Phys 108, 334-350.
23. Du K, Sharma M, & Lukacs GL (2005). The F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struc Mol Biol 12, 17-25.
24. Fatehi M & Linsdell P (2008). State-dependent access of anions to the cystic fibrosis transmembrane conductance regulator chloride channel pore. J Biol Chem 283, 6102-6109.
25. Fersht AR, Leatherbarrow RJ & Wells TNC (1986). Quantitative analysis of structure-activity relationships in engineered proteins by linear free-energy relationships. Nature 322, 284-286.
26. Fersht AR, Itzhaki LS, ElMasry NF, Matthews JM & Otzen DE (1994). Single versus parallel pathways of protein folding and fractional formation of structure in the transition state. Proc Natl Acad Sci U S A 91, 10426-10429.
27. Fersht AR (2004). Relationship of Leffler (Bronsted) α values and protein folding Φ-values to position of transition-state structure on reaction coordinates. Proc Natl Acad Sci U S A 101, 14338-14342.
28. Gadsby DC, Vergani P & Csanády L (2006). The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440, 477-483.
29. Grosman C, Zhou M & Auerbach A (2000). Mapping the conformational wave of acetylcholine receptor channel gating. Nature 403, 773-776.
30. He L, Aleksandrov A, Serohijos AWR, Hegedus T, Aleksandrov LA, Cui L, Dokholyan NV & Riordan JR (2008). Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J Biol Chem 283, 26383-26390.
31. Lape R, Colquhoun D & Sivilotti LG (2008). On the nature of partial agonism in the nicotinic receptor superfamily. Nature 454, 722-727.
32. Lewis HA, Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condon B, Maloney PC, Guggino WB, Hunt JF & Emtage S (2005). Impact of the F508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 280, 1346-1353.
33. Li C, Ramjeesingh M, Wang W, Garami E, Hewryk M, Lee D, Rommens JM, Galley K & Bear CE (1996). ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 271, 28463-28468.
34. Monod J, Wyman J & Changeux J-P (1965). On the nature of allosteric transitions: A plausible model. J Mol Biol 12, 88-118.
35. Oster G (2002). Darwin's motor. Nature 417, 25.
36. Purohit P, Mitra A & Auerbach A (2007). A stepwise mechanism for acetylcholine receptor channel gating. Nature 446, 930-933.
37. Rosenberg MF, Kamis AB, Aleksandrov LA, Ford RC & Riordan JR (2004). Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 279, 39051-39057.
38. Serohijos AW, Hegedus T, Aleksandrov AA, He L, Cui L, Dokholyan NV & Riordan JR (2008). Proc Natl Acad Sci U S A 105, 3256-3261
39. Seibert FS, Linsdell P, Loo TW, Hanrahan JW, Clarke DM & Riordan JR (1996). Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem 271, 15139-15145.
40. Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ & Hunt JF (2002). ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell 10, 139-149.
41. Straub JE & Karplus M (1990). The interpretation of site-directed mutagenesis experiments by linear free energy relations. Protein Eng 3, 673-675.
42. Thibodeau PH, Brautigam CA, Machius M & Thomas PJ (2005). Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struc Mol Biol 12, 10-16.
43. Vale RD & Oosawa F (1990). Protein motors and Maxwell's demons: Does mechanochemical transduction involve a thermal ratchet? Adv Biophys 26, 97-134.
44. Vergani P, Nairn AC & Gadsby DC (2003). On the mechanism of MgATP-dependent gating of CFTR Cl -channels. J Gen Physiol 121, 17-36.
45. Vergani P, Lockless SW, Nairn AC & Gadsby DC (2005). CFTR channel opening by ATP-driven tight dimerization of its nucleotide binding domains. Nature 433, 876-880.
46. Wang W, Bernard K, Li G & Kirk KL (2007). Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains. J Biol Chem 282, 4533-4544.
47. Winter MC, Sheppard DN, Carson MR & Welsh MJ (1994). Effect of ATP concentration on CFTR Cl -channels: A kinetic analysis of channel regulation. Biophys J 66, 1398-1403.
48. Zhou Y, Pearson JE & Auerbach A (2005). Φ-value analysis of a linear, sequential reaction mechanism: Theory and application to ion channel gating. Biophys J 89, 3680-3685.
49. Zolnerciks JK, Wooding C & Linton KJ (2007). Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB J 21, 3937-3948.